Literature DB >> 27588068

3D-DIR for early differential diagnostic and prognostic evaluation of NMO.

Yanbing Wang1, Hong Yan2, Qixing Ding2, Cunhua Mao3, Yelong Shen4, Guangbin Wang4.   

Abstract

Neuromyelitis optica (NMO) is an acute or subacute lesion of demyelinating disease involving the optic nerve and spinal cord, and imaging techniques and their effects have been the focus of investigations. The aim of the present study was to examine the value of three-dimensional double inversion recovery (3D-DIR) in the early differential diagnostic and prognostic evaluation of NMO. Forty-eight patients with suspicious NMO were included into the study and underwent a combination of serum NMO-IgG quantitative detection and 3D-DIR examination. Forty cases (83.3%) of the suspicious cases were confirmed with NMO. The average time from onset to definite diagnosis was 3.5±0.6 days. The brain showed high T2W and fluid-attenuated inversion recovery (FLAIR) signals, involving 5.8±1.2 sites on average, distributed in the peripheral lateral ventricle, medulla, cerebral white matter, the third ventricle, peripheral aqueduct of sylvius, pons and diencephalon. The average T2W signal strength was 2.73±0.12. The signal intensity of DIR was significantly higher than that of T2W and FLAIR, and the difference was statistically significant. The optic nerve and chiasma showed a high FLAIR signal, with an average signal intensity of 2.13±0.14. The spinal cord showed swelling, necrosis and cavity lesion, involving the gray and white matter of the central site, transversely, with an average lesion length of 4.7±0.6 centrum. The relative signal intensity of DIR was significantly higher than that of T2W and FLAIR. Following treatment, the signal intensity of the brain, optic nerve, optic chiasma and spinal cord decreased significantly (P<0.05). In conclusion, 3D-DIR has great application value in the early differential diagnostic and prognostic evaluation of NMO.

Entities:  

Keywords:  neuromyelitis optica; signal intensity; three-dimensional double inversion recovery

Year:  2016        PMID: 27588068      PMCID: PMC4998000          DOI: 10.3892/etm.2016.3474

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


Introduction

Neuromyelitis optica (NMO) is an acute or subacute lesion of demyelinating disease involving optic nerve and spinal cord (1). Previously, NMO was considered a clinical subtype of multiple sclerosis (MS), although the effects of clinical treatment were unsatisfactory (1,2). The development of imaging technology identified NMO and MS as different with regard to the characteristics of lesions. By applying two inversion pulses, three-dimensional double inversion recovery (3D-DIR) sequence significantly improved the signal contrast of different tissues and the imaging effects of gray matter lesions (3). In recent years, 3D-DIR has been gradually applied in the diagnosis of epilepsy, MS and other diseases, and the effects have proven to be satisfactory (4–6). The aim of the present study was to examine the application value of 3D-DIR in the early differential diagnostic and prognostic evaluation of NMO.

Materials and methods

Patients

In total, 48 patients diagnosed with suspicious NMO at the Rizhao People's Hospital between October 2013 and October 2015 were included into the present study. All 48 patients were confirmed to be first onset and first treatment according to the clinical symptoms and physical signs. Of the 48 patients, there were 10 males and 38 females including 7 children. The patient age range was 8–66 years, with a median age of 43.5 years, and a time of onset ranging from 1 to 3 days with an average of 1.7±0.5 days. The patients with central nervous demyelinating lesions such as MS, definite infection history, cerebral tumor, epilepsy, pregnancy, consciousness disturbance and those who refused to participate were excluded. Approval for the present study was obtained from the ethics committee of the Rizhao People's Hospital. Patients and their families/guardians provided informed consent.

Methods

The patients were given a combined NMO-IgG quantitative detection and 3D-DIR examination as well as standard medical drug therapy. For the 3D-DIR examination, a Siemens MAGNETOM Skyra 3.0T superconducting scanner (Siemens Healthcare GmbH, Erlangen, Germany) and 8-channel head coil were used to perform the routine MR examination. Fast spin echo (TSE) T2WI, fluid-attenuated inversion recovery (FLAIR) sequence and 3D-DIR sequence were examined in turn. Parameters of the 3D-DIR sequence included (TR 7,500 msec, TE 308 msec; T1 3,000 msec; matrix 190×192; visual field of FOV 256×256 mm; 128 layers; and thickness of 1.3 mm), two reversal pulses, TI1 (time from the first 180° reverse pulse to 90° drive pulse) 3,400 msec, and parameters of TI2 (time from the second 180° reverse pulse to 90° drive pulse) 325 msec. Subsequently, T2W TSE sequence (TR 5,000 msec, TE 87 msec; matrix 256×256; FOV 256×256 mm; 35 layers; thickness of 4 mm) scanning was performed. According to the anatomical location of the lesions in MRI, the lesions were divided into: endodermal lesions, gray and white matter mixed lesions, subcortical lesions, deep gray matter lesions and white matter lesions.

Observation indexes

The signal characteristics of the 3D-DIR scan of the cerebral and spinal cord lesions of NMO and MS patients were compared, and the signal characteristics of 3D-DIR scan of NMO patients prior and subsequent to surgery were compared.

Statistical methods

SPSS 20.0 statistical software (Chicago, IL, USA) was used for statistical analysis. Measurement data were presented as mean ± standard deviation. Enumeration data were expressed as a percentage (%). The group comparison was made using the χ2 test. P<0.05 was considered to be statistically significant.

Results

Signal characteristics of 3D-DIR scaning of NMO patients

The diagnostic criteria for NMOSD revised by Wingerchuk et al in 2015 (7) indicated: i) at least one core clinical characteristic, ii) positive test for AQP4-IgG using the best available detection method, and iii) exclusion of alternative diagnoses. At least one core clinical characteristic (optic nerve) was neuritis and acute myelitis, with the supporting standard (met at least two requirements) being: spinal cord MRI lesion extended at least three segments, head MRI failed MS diagnostic criteria, and positive serum NMO-IgG. Forty cases (83.3%) were confirmed with NMO, and the time from onset to diagnosis was 3.5±0.6 days on average. The brain of NMO patients showed low T1W signal, high T2W and FLAIR signals, involving 5.8±1.2 sites on average, and being distributed in the peripheral lateral ventricle, medulla, cerebral white matter, the third ventricle, peripheral aqueduct of sylvius, pons and diencephalon. The average T2W signal strength was 2.73±0.12, average FLAIR signal strength was 2.56±0.23 and the average DIR signal strength was 2.89±0.32. The signal intensity of T2W, FLAIR and DIR of NMO patients was significantly higher than that of MS patients, with the average sites involved being more than those of MS patients (P<0.05) (Table I and Fig. 1).
Table I.

Brain signal characteristics of NMO patients.

GroupT2WFLAIRDIRMean involved parts
NMO patients2.73±0.122.56±0.232.89±0.325.8±1.2
MS patients2.84±0.152.77±0.253.04±0.222.7±0.6
t4.2514.1894.2375.324
P-value0.0430.0440.0420.038

NMO, neuromyelitis optica; FLAIR, fluid-attenuated inversion recovery; DIR, double inversion recovery.

Figure 1.

(A) Optic chiasma showed high FLAIR signal with an average signal intensity of 2.13±0.14. (B and C) DIR transverse and coronal view shows higher signals with an average signal intensity of 2.37±0.23. FLAIR, fluid-attenuated inversion recovery; DIR, double inversion recovery.

Signal characteristics of 3D-DIR scan of NMO patients prior to and after treatment

Following treatment, the signal intensity of the brain, optic nerve, optic chiasma and spinal cord decreased significantly, and the differences were statistically significant (P<0.05) (Table II, and Figs. 2 and 3).
Table II.

Signal characteristics of 3D-DIR scan of NMO patients before and after treatment.

T2WFLAIRBrain 3D-DIROptic nerve FLAIROptic nerve 3D-DIRSpinal cord 3D-DIRSpinal cord FLAIR
Pre-treatment2.73±0.122.56±0.232.84±0.252.13±0.142.37±0.232.17±0.241.98±0.22
Post-treatment1.35±0.131.42±0.211.63±0.241.77±0.151.98±0.171.83±0.211.63±0.18
t4.6474.7955.3215.1025.6245.6984.968
P-value0.0370.0360.0320.0340.0210.0170.035

3D-DIR, three-dimensional double inversion recovery NMO, neuromyelitis optica; FLAIR, fluid-attenuated inversion recovery.

Figure 2.

Prior to treatment (A) T2 image; (B) enhanced scanning. After treatment (C) T2 and (D) DIR image shows decreased signal, reduced lesion scope and amyelotrophy. DIR, double inversion recovery.

Figure 3.

Brain (A) T2WI (B) FLAIR (C) DIR (D) FLAIR and (E) DIR. FLAIR, fluid-attenuated inversion recovery; DIR, double inversion recovery.

Discussion

NMO is a type of demyelinating disease that occurs in the central nerve system. Its pathological features include failure of the nerve fiber myelin sheath and the presence of multiple small disseminated disease or relatively large lesions infused by one or more lesions, distributed in white matter and infiltrating along the inflammatory cells surrounding veinlet; neurons, axons, and supporting tissues that remain relatively intact, free from wallerian degeneration or secondary bundle degeneration (8). The etiology and mechanism of NMO remain unknown, but may be associated with genetic quality and ethnic differences (9). NMO mainly involves the optic nerve, optic chiasma and spinal cord, and lesions appearing in the thoracic and cervical segments, which is different from typical MS. Additionally, its destructive lesions are more obvious and axonal destruction may also be present (10). Although NMO-IgG has 91% specificity and 73% sensitivity in the diagnosis of NMO, the NMO-IgG of most MS patients are negative. Nevertheless, in clinic, imaging diagnosis remains the first choice for the early diagnosis of NMO (11,12). MRI is the first choice for the imaging diagnosis of NOM, but the spatial and contrast resolution of conventional MR pulse sequences is not efficient and requires improvement in displaying gray matter lesions (13,14). The 3D-DIR pulse sequence uses pulses that may inhibit the cerebrospinal fluid and white matter signals, better display the gray matter of the brain, improve the sensitivity of gray matter lesions, and identify cortical lesions that may not be detected by conventional MR pulse sequence (13–15). In the DIR sequence, selecting two TI values (TI1 and TI2) according to the longitudinal relaxation time (T1) of the tissues to be imaged, and in brain scanning, selecting corresponding TI1 and TI2 values may inhibit cerebrospinal fluid and white matter signals at the same time and better display the gray matter of the brain (16,17). At present, it is rarely used in the study of NMO. In the present study, by comparing the imaging characteristics of NMO and MS, we found that: i) the brain of NMO patients showed a low T1W signal, high T2W and FLAIR signals, involving on average 5.8±1.2 sites, distributed in the peripheral lateral ventricle, medulla, cerebral white matter, the third ventricle, peripheral aqueduct of sylvius, pons and diencephalon. AQP4 was similarly highly expressed around the aqueductus Sylvii, ventriculus quartus cerebri and central canal (18). The enhancement of Gd-DTPA was varied, periventricular, pia mater enhancement, corpus callosum linear, and zonal enhancement exhibited specificity (19). The ii) optic nerve and chiasma showed a high FLAIR signal. In the acute period, the spinal cord showed swelling, necrosis and cavity lesions, lesions were enhanced after enhanced scanning, involving primarily gray matters and partial white matters of the central part, transversely, with the average length of the lesion being 4.7±0.6 centrum (Fig. 4), mostly located in neck and thoracic cord, and the lesions of cervical segment can extend up to the lower part of the medulla, and during recovery, the spinal cord in lesion site was able to shrink (19,20). The results of the present study show that the signal intensity of T2W, FLAIR and DIR of NMO patients were significantly higher than those of the MS patients, the average of sites involved were significantly more than those of the MS patients. In addition, after the follow-up of the present study, it was found that the signal intensity of head, optic nerve, optic chiasma and spinal cord following treatment were significantly lower than those prior to treatment.
Figure 4.

(A) T2WI spinal cord shows swelling, necrosis and cavity lesion, involving the gray and white matter of the central site, transversely, and the average length of the lesion was 4.7±0.6 centrum. (B) DIR shows higher signal. Lesions of MS patients were located in the peripheral spinal cord and the average length of the lesion was 0.9±0.2 centrum. DIR, double inversion recovery; MS, multiple sclerosis.

In summary, 3D-DIR was not only of great reference value for the early differential diagnosis of NMO, but also valuable for the evaluation of prognosis of patients.
  20 in total

1.  Double inversion recovery magnetic resonance imaging at 3 T: diagnostic value in hippocampal sclerosis.

Authors:  Qiong Li; Quan Zhang; Haoran Sun; Yunting Zhang; Renju Bai
Journal:  J Comput Assist Tomogr       Date:  2011 Mar-Apr       Impact factor: 1.826

2.  Anterior temporal lobe white matter abnormal signal (ATLAS) as an indicator of seizure focus laterality in temporal lobe epilepsy: comparison of double inversion recovery, FLAIR and T2W MR imaging.

Authors:  Emiko Morimoto; Mitsunori Kanagaki; Tomohisa Okada; Akira Yamamoto; Nobuyuki Mori; Riki Matsumoto; Akio Ikeda; Nobuhiro Mikuni; Takeharu Kunieda; Dominik Paul; Susumu Miyamoto; Ryosuke Takahashi; Kaori Togashi
Journal:  Eur Radiol       Date:  2012-07-19       Impact factor: 5.315

3.  Cortical lesion counts by double inversion recovery should be part of the MRI monitoring process for all MS patients: yes.

Authors:  Massimiliano Calabrese; Nicola De Stefano
Journal:  Mult Scler       Date:  2014-04       Impact factor: 6.312

4.  Comparison of 3D double inversion recovery and 2D STIR FLAIR MR sequences for the imaging of optic neuritis: pilot study.

Authors:  Jérôme Hodel; Olivier Outteryck; Anne-Laure Bocher; Hélène Zéphir; Oriane Lambert; Mohamed Amine Benadjaoud; David Chechin; Jean-Pierre Pruvo; Patrick Vermersch; Xavier Leclerc
Journal:  Eur Radiol       Date:  2014-08-23       Impact factor: 5.315

5.  Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression.

Authors:  Sean J Pittock; Brian G Weinshenker; Claudia F Lucchinetti; Dean M Wingerchuk; John R Corboy; Vanda A Lennon
Journal:  Arch Neurol       Date:  2006-07

6.  Acute severe memory impairment as a presenting symptom of multiple sclerosis: a clinical case study with 3D double inversion recovery MR imaging.

Authors:  J A F Coebergh; S D Roosendaal; C H Polman; J J Geurts; T C A M van Woerkom
Journal:  Mult Scler       Date:  2010-09-16       Impact factor: 6.312

7.  Magnetic resonance imaging of optic neuritis in patients with neuromyelitis optica versus multiple sclerosis.

Authors:  Sangeeta Khanna; Aseem Sharma; Julie Huecker; Mae Gordon; Robert T Naismith; Gregory P Van Stavern
Journal:  J Neuroophthalmol       Date:  2012-09       Impact factor: 3.042

Review 8.  Magnetic resonance imaging in neuromyelitis optica.

Authors:  George Tackley; Wilhelm Kuker; Jacqueline Palace
Journal:  Mult Scler       Date:  2014-05-14       Impact factor: 6.312

9.  "Cloud-like enhancement" is a magnetic resonance imaging abnormality specific to neuromyelitis optica.

Authors:  Shoichi Ito; Masahiro Mori; Takahiro Makino; Sei Hayakawa; Satoshi Kuwabara
Journal:  Ann Neurol       Date:  2009-09       Impact factor: 10.422

10.  International consensus diagnostic criteria for neuromyelitis optica spectrum disorders.

Authors:  Dean M Wingerchuk; Brenda Banwell; Jeffrey L Bennett; Philippe Cabre; William Carroll; Tanuja Chitnis; Jérôme de Seze; Kazuo Fujihara; Benjamin Greenberg; Anu Jacob; Sven Jarius; Marco Lana-Peixoto; Michael Levy; Jack H Simon; Silvia Tenembaum; Anthony L Traboulsee; Patrick Waters; Kay E Wellik; Brian G Weinshenker
Journal:  Neurology       Date:  2015-06-19       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.